Definitive Contract HHSD200201691082C
- Not listed
- The U.S. Department of Health and Human Services (HHS) awarded a $240,491.71 firm-fixed-price purchase order to OraSure Technologies Inc. (doing business as OraSure) for the acquisition of Filovirus Point-of-Care (POC) diagnostic tests. The award, which has no set-aside designation, supports the procurement of a minimum of 8,500 lateral flow, rapid antigen tests for Ebola virus that can be used on oral fluids from cadavers and have a nine-month shelf life. OraSure is the only current provider...
- This is a federal contract award to Orasure Technologies Inc., a for-profit manufacturer of diagnostic medical testing products, to modify the OraQuick test platform to enable antigen detection of the Ebola Zaire virus for use with various sample types. The purpose of this $11,937,826.99 cost-plus-fixed-fee contract modification is to transfer all government property associated with the original contract to a new contract. The contract is funded by the Office of the Assistant Secretary for...
- This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Orasure Technologies Inc., a for-profit manufacturer of medical diagnostic products. The contract is for the development and production of the OraQuick Zika Point-of-Care Test, with a ceiling value of $4,969,092.67. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and an...
- This federal contract award, valued at $388,440,000.00, was issued by the Defense Logistics Agency Troop Support Medical to Orasure Technologies Inc., a for-profit manufacturer of diagnostic medical testing products. The contract is for the delivery of InteliSwab COVID-19 Rapid Test Kits, a type of over-the-counter COVID-19 diagnostic test. The contract has an ultimate completion date of October 6, 2022 and was awarded on October 20, 2021. No set-aside designation was used for this contract....
- The federal contract award with ID SPE2DE21D0049|SPE2DS21F0125 was issued by the Defense Logistics Agency Troop Support Medical, a defense agency, to Orasure Technologies Inc., a for-profit manufacturer headquartered in Bethlehem, Pennsylvania. The $56,423,400.00 firm fixed price delivery order is for the provision of 8508548459 ORASURE COVID-19 test kits. This award is associated with Orasure's $107.28 million single-award Indefinite Delivery Contract with the Defense Logistics Agency, which...
- This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. is valued at $710,310 to support the development of a rapid antigen test for COVID-19. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002 and will deliver research and development efforts towards a host-directed therapeutic to aid long-term outcomes from lung...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $30.88 million definitive contract to Orasure Technologies Inc., doing business as Orasure, to provide COVID-19 home test industrial base expansion transitioning from the Department of Defense/Air Force to HHS/ASPR. The contract is for COVID-19 DIB FOR ORASURE TECHNOLOGIES COVID-19 HOME TEST INDUSTRIAL BASED EXPANSION TRANSITIONING FROM THE DOD/AF TO HHS/ASPR under Department...
- The Defense Logistics Agency Troop Support Medical awarded a $2,340.00 Firm Fixed Price Purchase Order to Orasure Technologies Inc., a manufacturer of medical diagnostic products, for the delivery of Alcohol Detection Test Kits. The contract has a completion date of March 11, 2024. Orasore Technologies Inc., also known as Orasure, is a global company that develops, manufactures, and markets a range of oral fluid diagnostic products and specimen collection devices, including rapid tests for...
- Orasure Technologies Inc., doing business as Orasure, has been awarded a four hundred seventy-eight dollar delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract vehicle. The fixed-price with economic price adjustment contract calls for Orasure to provide COVID-19 over-the-counter test kits to the United States government by December 10, 2021. Awarded on December 4, 2021 without a set-aside designation, this delivery order...
- Orasure Technologies Inc., doing business as Orasure, has been awarded a four hundred seventy-eight dollar delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical. The fixed price with economic price adjustment contract calls for Orasure to provide COVID-19 over-the-counter test kits to the agency by December 13, 2021. The award is associated with the Coronavirus COVID-19 national interest action code. Performance will take...
This federal contract award to Orasure Technologies Inc. (Orasure) is for the procurement of OraQuick Ebola Rapid Antigen Tests by the Centers for Disease Control and Prevention (CDC). The definitive contract, valued at $278,620.89, was awarded on August 1, 2016 with a completion date of November 30, 2016. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Orasure is a global manufacturer of oral fluid diagnostic products and specimen collection devices, including rapid tests for diseases such as HIV, Hepatitis C, and COVID-19. The company has received significant prime contract funding from federal agencies like the Defense Logistics Agency Troop Support Medical and the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response for the procurement of various medical diagnostic kits and supplies. Orasure also holds two key indefinite delivery vehicles (IDVs) - a single-award IDC with the Defense Logistics Agency Troop Support Medical valued at up to $107.28 million, and a multiple-award IDV on the GSA Federal Supply Schedule 65-VII for In-vitro Diagnostics, Reagents, and Test Kits with a $6.38 million ceiling.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||